Zobrazeno 1 - 10
of 223
pro vyhledávání: '"Tombuloglu, M."'
9th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 17-20, 2018 -- Istanbul, TURKEY
Saydam, Guray/0000-0001-8646-1673; Sahin, Fahri/0000-0001-9315-8891
WOS:000447176600059
[No Abstract Available]
Saydam, Guray/0000-0001-8646-1673; Sahin, Fahri/0000-0001-9315-8891
WOS:000447176600059
[No Abstract Available]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::eaf5a28ab73d114ae949c97600ac7283
https://hdl.handle.net/11454/70592
https://hdl.handle.net/11454/70592
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sahin, F., Patir, P., Soyer, N. Akad, Durusoy, R., Saydam, G., Tobu, M., Tombuloglu, M., Vural, F.
22nd Congress of the European-Hematology-Association -- JUN 22-25, 2017 -- Madrid, SPAIN
WOS: 000404127005030
European Hematol Assoc
WOS: 000404127005030
European Hematol Assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::dc943789ee2a4511b9f5d60c925f0a51
https://hdl.handle.net/11454/32019
https://hdl.handle.net/11454/32019
Autor:
Tombuloglu M., Saydam, G.., Donmez A., Cagirgan S., Hekimgil M., Soydan S., Sencan M., Buyukkececi F.
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology. 16(4)
POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes) is a rare disease and constitutes 1-2% of plasma cell dyscrasia. Most of the patients have few sclerotic bone lesions and more than 90% of patients have serum a
Autor:
Ozdemirkiran, F, Payzin, B, Kiper, HD, Kabukcu, S, Cagliyan, GA, Kahraman, S, Sevindik, OG, Ceylan, C, Kadikoylu, G, Sahin, F, Keskin, A, Arslan, O, Ozcan, MA, Gorgun, G, Bolaman, Z, Buyukkececi, F, Bilgir, O, Alacactoglu, I, Vura, F, Tombuloglu, M, Gokgoz, Z, Saydam, G
Objective: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L. Although it is included in a benign disease group, bleeding complications may be mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::119906e1c74e48ce2899a4cc4d3172b7
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/22668
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/22668
Autor:
Unal, H. D. Kiper, Soyer, N., Vural, F., Sahin, F., Tobu, M., Donmez, A., Tombuloglu, M., Arda, B., Saydam, G.
19th Congress of the European-Hematology-Association -- JUN 12-15, 2014 -- Milan, ITALY
WOS: 000342830903436
European Hematol Assoc
WOS: 000342830903436
European Hematol Assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::1bfb2ad5a186d34f891e12ce2e7fdc7e
https://hdl.handle.net/11454/50022
https://hdl.handle.net/11454/50022
Autor:
Vural F., Karaca E., Soyer N., Gunduz C., Sahin F., Kosova B., Saydam, G.., Cagirgan S., Tombuloglu M., Özkınay F., Cogulu O.
Chronic Lymphocytic Leukemia (CLL) is the most common leukemia in adults. Recently CD38, ZAP70 and hTERT activity have been studied for the evaluation of the prognosis of CLL besides clinical staging and lymphocyte doubling time. There are inconsiste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::8e7999e08b1ddc99de3278ec0163e479
https://hdl.handle.net/11454/26195
https://hdl.handle.net/11454/26195
Autor:
Vural, F., Yilmaz, A., Savas, R., Gunes, A., Saydam, G., Sahin, F., Comert, M., Tobu, M., Gokgoz, Z., Dogan, E., Tombuloglu, M.
WOS: 000445772400864
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::98292edb269745c0354facdff4de46d4
https://hdl.handle.net/11454/47430
https://hdl.handle.net/11454/47430
WOS: 000445782800722
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::0595d5dce9a3c52ce64d655003e43d08
https://hdl.handle.net/11454/47438
https://hdl.handle.net/11454/47438
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.